# Fulvestrant

NDC: 71288-555
Generic name: Fulvestrant
Labeler / Manufacturer: Meitheal Pharmaceuticals Inc
Product type: HUMAN PRESCRIPTION DRUG
Marketing category: Abbreviated NDA (generic)
Dosage form: INJECTION
Routes: INTRAMUSCULAR
Marketing started: 20191121
Marketing ended: 20270131
FDA application: ANDA209714

## Active ingredients

- FULVESTRANT: 50 mg/mL

## Pharmacological class

—

## External sources

- openFDA: https://api.fda.gov/drug/ndc.json?search=product_ndc:"71288-555"
- FDA NDC Directory: https://www.accessdata.fda.gov/scripts/cder/ndc/dsp_searchresult.cfm?p_ndc=71288-555
- DailyMed: https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=015fafb6-23f7-4566-9c23-386eee7b035d